As cellular and bispecific immunotherapies move into earlier treatment lines, pharmacists are interpreting new guidelines, managing toxicities, and shaping patient care strategies.
Ariel D. Dixon, PharmD, BCOP
Advertisement
Articles by Ariel D. Dixon, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
2
KEYNOTE Trial Data Presented at ESMO 2025 Congress Reiterate Pembrolizumab’s Benefits in NSCLC
3
FDA, HHS Move to Accelerate Biosimilar Approvals
4
Burnout Among Pharmacy Technicians Demands Urgent Action
5
